THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY AND INTENSITY-MODULATED RADIATION THERAPY COMBINED WITH TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION FOR LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA: AN IRRADIATION DOSE ESCALATION STUDY

THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY AND INTENSITY-MODULATED RADIATION THERAPY COMBINED WITH TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION FOR LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA: AN IRRADIATION DOSE ESCALATION STUDY
复制标题

DOI:
10.1016/j.ijrobp.2009.10.070
复制
发表时间:
2011-02-01
影响因子:
7
通讯作者:
Jiang, Guo-Liang
Jiang, Guo-Liang
中科院分区:
医学1区
文献类型:
--
作者:
Ren, Zhi-Gang;Zhao, Jian-Dong;Jiang, Guo-Liang

文献摘要

被引文献

相似文献

目的:探讨三维适形放疗(3DCRT)/调强放疗(IMRT)联合经导管动脉化疗栓塞治疗局部晚期肝癌的最大耐受剂量(MTD)。方法与材料:根据肿瘤直径将患者分为2个亚组:1组肿瘤= 10 cm;两组中每个队列的剂量均增加4.0 Gy。剂量限制性毒性(DLT)被定义为>= 3级急性肝脏或胃肠道毒性或任何5级急性其他器官毒性或辐射引起的肝脏疾病。当队列中8例患者中>= 2例发生DLT时,剂量递增将终止。结果:2005年4月至2008年5月,共纳入40例患者。在第一组,11例患者有分级
Purpose: To determine the maximum tolerated dose (MTD) of three-dimensional conformal radiation therapy (3DCRT)/intensity-modulated radiation therapy (IMRT) combined with transcatheter arterial chemoembolization for locally advanced hepatocellular carcinoma.Methods and Materials: Patients were assigned to two subgroups based on tumor diameter: Group 1 had tumors = 10 cm. Escalation was achieved by increments of 4.0 Gy for each cohort in both groups. Dose-limiting toxicity (DLT) was defined as a grade of >= 3 acute liver or gastrointestinal toxicity or any grade 5 acute toxicity in other organs at risk or radiation-induced liver disease. The dose escalation would be terminated when >= 2 of 8 patients in a cohort experienced DLT.Results: From April 2005 to May 2008,40 patients were enrolled. In Group I, 11 patients had grade